Patent ID: 11912754
Assignee: IMMUNOWAKE INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. An antibody fusion protein comprising 1) an antibody comprising a first light chain and a second light chain, and 2) a first vascular endothelial growth factor receptor (VEGFR) component and a second VEGFR component, wherein the first VEGFR component is fused to the C-terminus of the first light chain, and the second VEGFR component is fused to the C-terminus of the second light chain; wherein the first VEGFR component and the second VEGFR component each comprises the amino acid sequence of SEQ ID NO: 8; and wherein the antibody specifically recognizes an immune checkpoint molecule, a tumor antigen, or an angiogenic factor.